FDA accepts Replimune RP1 BLA resubmission for advanced melanoma
Go back to FDA accepts Replimune RP1 BLA resubmission for advanced melanoma| Rider Explorations, Inc. (NASDAQ: REPL) | Delayed: 10.46 -0.29 (2.7%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $10.75 | 52 Week High | $1.45 | |||
| Open | $10.71 | 52 Week Low | $0.50 | |||
| Day High | $10.98 | P/E | N/A | |||
| Day Low | $10.27 | EPS | $0.00 | |||
| Volume | 3,791,594 | |||||
